✨ Your Portfolio is fetched and updated from zerodha.
Micro
Market Cap
₹1,214 Cr.
P/E
24.76

Key Ratios

Market cap
Market cap
1,214 Cr
PE
PE
24.76
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
14.39
ROCE (%)
ROCE (%)
19.28
Div Yield (%)
Div Yield (%)
0.18
Sales
Sales
99.27 Cr
OPM (%)
OPM (%)
51.38 %
Debt to Equity
Debt to Equity
-
About
3B Blackbio Dx is in the Miscellaneous sector with a M.cap of 1214.00 Cr and a PE rati… Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on 3B Blackbio Dx Ltd. Business

Established in 1972, KILPEST is a leading Agri-based company in India. Initially the only pesticide formulating company in Madhya Pradesh, it has grown to manufacture 50 pesticide products, microfertilizers, biofertilizers, and biopesticides in Central India.

3B Blackbio Dx major competitors are TTK Healthcare, Nureca Ltd., QMS Medi Allied Ser., Poly Medicure, Max India, Sastasundar Ventures, Amrutanjan Healthcar.
Market Cap of 3B Blackbio Dx is ₹1,214 Crs.
While the median market cap of its peers are ₹1,152 Crs.

3B Blackbio Dx seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Sep Dec Mar Jun Sep
Investor Presentation May Aug Mar Jun Sep Dec Mar Jun Dec Mar Jun Aug Sep Dec Mar Jun Mar Jun Sep Dec Jun Sep Dec Dec
Conference Call Jun
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material